NB
OTC · NBIO
Nascent Biotech, Inc.
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Aug 24, 2026, 4:16 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 51.67K
- P/E ratio
- -0.08
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.13
- Volume
- 351.06K
- Avg. volume
- 24.74K
Price performance
NBIO price history
1M range · 3 trading sessions · Daily adjusted prices
NBIO closed at $0.00 after 3 trading sessions, up 50.00% for the selected period.
- Last close
- $0.00
- Period change
- +50.00%
- Period low
- $0.00
- Period high
- $0.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 351.06K |
| Aug 6, 2026 | $0.0002 | $0.0003 | $0.0002 | $0.0003 | 8.5K |
| Aug 4, 2026 | $0.0001 | $0.0002 | $0.0001 | $0.0002 | 609.06K |
Latest NBIO news
The latest Smart Investors Daily articles mentioning NBIO.
Stock researchCompany · Overview
NBIO research
Overview
Company profile and research snapshot.
Company profile
NASCENT BIOTECH INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
